Condition: Sickle Cell · Sickle Cell Disease · Vaso-Occlusive Crises · Sponsor: Centre Hospitalier Universitaire de la Guadeloupe
Sickle cell disease is a chronic disease characterized by multiple vaso-occlusive complications. The basic treatment for patients with a vaso-occlusive crisis (VOC) is based on adequate hydration, oxygen therapy and pain control. Loco Regional Anesthesia (LRA) is one of the major treatments in resuscitation anesthesia for both anesthesia and analgesia. LRA allows effective and almost immediate pain control by blocking nerve afferents in a given area. LRA could decrease the inflammatory response during crises and accelerate resolution of the crisis.
This description comes directly from the study's public registry record.
Valérie Hamony Soter · +590590934677 · valerie.soter@chu-guadeloupe.fr
Mélanie Petapermal · +590590934667 · melanie.petapermal@chu-guadeloupe.fr
Always discuss trial participation with your own doctor first.
| Chu de La Guadeloupe | Pointe-à-Pitre, Guadeloupe | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07001189